Human activating signal cointegrator homology (ASCH) domain-containing proteins are widespread and diverse but, at present, the vast majority of those proteins have no function assigned to them. This study demonstrates that the 103-amino acid Escherichia coli protein YqfB, previously identified as hypothetical, is a unique ASCH domain-containing amidohydrolase responsible for the catabolism of N 4 -acetylcytidine (ac4C). YqfB has several interesting and unique features: i) it is the smallest monomeric amidohydrolase described to date, ii) it is active towards structurally different N 4 -acylated cytosines/cytidines, and iii) it has a high specificity for these substrates (k cat /K m up to 2.8 × 10 6 M −1 s −1 ). Moreover, our results suggest that YqfB contains a unique Thr-Lys-Glu catalytic triad, and Arg acting as an oxyanion hole. The mutant lacking the yqfB gene retains the ability to grow, albeit poorly, on N 4 -acetylcytosine as a source of uracil, suggesting that an alternative route for the utilization of this compound exists in E. coli. Overall, YqfB ability to hydrolyse various N 4 -acylated cytosines and cytidines not only sheds light on the long-standing mystery of how ac4C is catabolized in bacteria, but also expands our knowledge of the structural diversity within the active sites of amidohydrolases.
Results and Discussion
Enzyme detection and characterisation. To test if an enzyme active towards ac4C exists in Escherichia coli, cell-free extracts of several E. coli strains were analysed. We observed that both the ac4C and N 4 -acetylcytosine were readily converted to cytidine and cytosine, respectively, in cell-free extracts of E. coli DH5alpha, DH10B, and BL21(DE3). To identify the enzyme involved in hydrolysis, we purified the active protein from E. coli DH10B cells by the application of several chromatographic steps (Fig. 1a ). The MS/MS analysis of the active protein (~12 kDa) excised from the native gel ( Fig. 1b, Supplementary Table 2 ) identified the ASHC superfamily protein (Fig. 1c ) encoded by the yqfB gene. Although the 3D structure of YqfB has been published previously 17 , no data on its biological activity is available to date.
To analyse the catalytic properties of YqfB in more detail, the E. coli yqfB gene was cloned and the recombinant proteins without any tag as well as those with a His 6 tag at either N-or C-terminus were purified to homogeneity (Fig. 1d ). An E. coli BL21(DE3) yqfB::Km strain was used for YqfB production, with no interference from the chromosomal gene. Gel chromatography revealed that YqfB existed as a monomer, under tested conditions ( Supplementary Fig. 2 ). YqfB was most active at pH 8.0 and preferred temperatures below 20 °C ( Supplementary Figs. 3 and 4) . Based on the substrate range of YqfB-catalysed reactions (Fig. 1e) , the enzyme is active towards a wide range of N 4 -acylcytosines/cytidines, and the bulky groups at 5′ position are tolerated ( Table 1 , Supplementary Figs. 5-10 ). The highest k cat /K m value ( Table 2 , examples of kinetic traces Supplementary  Fig. 16 ) suggests that ac4C is likely the natural substrate of YqfB. Inhibition with the reaction product was also observed. However, the catalytic activity of YqfB was unaffected by known inhibitors of amidohydrolases: PMSF, p-hydroxymercuribenzoate (up to 2 mM), p-chloromercuribenzoate (up to 1 mM), and EDTA (up to 5 mM). Since EDTA had no influence on the reaction rate, we presumed that bivalent metal ions do not participate in the deacetylation reaction. Supplementary Fig. 10A ), lane 2 -the corresponding unstained gel. The gel slices (s1-s4) were incubated with ac4C and the reaction products were analysed by TLC ( Supplementary Fig. 1 ). The gel slice (s4) with hydrolase activity was applied for MS/MS analysis. Supplementary Fig. 17B ); lane 1 -molecular mass marker, lane 2-13.5 µg of YqfB. (e) Scheme of the reaction catalysed by YqfB. An asterisk marks the carbon atom to which the group was linked. The structures of all tested substrates are listed in Table 1 . 
Continued
To elucidate the function of YqfB in vivo, the yqfB gene was replaced with a kanamycin resistance cassette in the uracil auxotrophic strain E. coli DH10BΔpyrFEC 18 . DH10BΔpyrFEC and DH10BΔpyrFEC yqfB::Km mutants, lacking cytosine deaminase CodA 19 , could not survive without uracil in the growth medium, and did not accept cytosine or N 4 -acetylcytosine as a source of uracil ( Fig. 2 ). When these mutants were expressing either CodA or CodA and YqfB, their growth was observed on both cytosine and N 4 -acetylcytosine, suggesting that both compounds were converted to uracil. Although the mutant lacking the yqfB gene was capable of growing on N 4 -acetylcytosine as a source of uracil, the growth was poor compared with that of the strain with intact yqfB gene. These results clearly show that YqfB participates in the catabolism of N 4 -acetylcytosine, however an alternative route for the utilization of this compound may exist in E. coli.
Analysis of the catalytic amino acids. Next, to identify amino acids relevant for catalysis, we analysed multiple sequence alignments for the ASCH family. This allowed the identification of sequences closely related to YqfB, representing a separate branch in the phylogenetic tree ( Supplementary Fig. 11 ). These sequences ( Fig. 3 ) were realigned using MAFFT method, and the new alignment was further analysed. From the alignment we identified a set of 100% conserved amino acids (namely, Lys21, Thr24, Arg26, Asp27, His70, Glu74, and Tyr89) that were each individually replaced with alanine. The soluble mutant proteins were obtained, purified ( Supplementary Fig. 12 ), and their catalytic properties were investigated ( Table 3 , Supplementary Fig. 16 ). The enzyme variants Arg26Ala, Thr24Ala and Lys21Ala were catalytically inactive. With ac4C and N 4 -acetylcytosine, the turnover number of the Glu74Ala mutant was found 1000-fold and 100-fold lower, respectively, than that of N 4 -(2-acetyl-benzoyl)-2′-deoxycytidine-5′-triphosphate (21 Table 1 . A list of compounds tested as substrates for YqfB. UV -spectrophotometric assay, TLC -activity analysed by thin layer chromatography, HPLC-MS -analysis using a high performance liquid chromatography system and a mass spectrometer. An asterisk marks the carbon atom to which the group was linked.
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From these results, a hypothesis regarding the catalysis mechanism may be inferred: Lys21 functions as a base, Thr24 as a nucleophile, and Glu74 as an acid, in a mechanism fairly typical of hydrolases. To the best of our knowledge, such catalytic triad with threonine acting as a nucleophile was observed for the first time in amidohydrolases, except for the enzymes that harbour a post-translationally formed N-terminal threonine acting as a nucleophile 20, 21 . Notably, in support of our hypothesis regarding the amino acids relevant to the mechanism of catalysis, the YqfB Thr24Ser mutant that has a classical catalytic triad of amidohydrolases shows roughly the same catalytic activity as the wild-type YqfB.
Structural basis for YqfB catalytic activity. Later, we tried to relate the observed properties of mutants with the three-dimensional structure of wild type YqfB that was published in 2005 (PDB ID:1te7) 17 . Surprisingly, the 1te7 structure failed to provide any reasonable insights into the mechanism of catalysis by YqfB. The essential Thr24 was buried deep in the structure and was not accessible through any pocket to bind the substrate. Lys21, Glu74 and His70 were far removed from Thr24 and were exposed on the surface of structure. Such discrepancy between our results and the published data might be due to the poor quality of the structure deposited to the database, as seen from the wwPDB NMR structure validation report. To investigate this issue, we carried out a series of molecular dynamics (MD) simulations of the structure with built-in disulphide bridge between Cys51 and Cys102 (only 2.07 ± 0.07% of YqfB contained free SH groups, Supplementary Table 3 ) and that of the disulphide bridge free YqfB variant (as in the published structure). In both cases, over the simulation duration of 2 µs, the structures rapidly unfolded and then slowly folded into rather different ones ( Supplementary Fig. 6A ) indicating that the published structure is not completely correct. To overcome this, we used a homology modelling approach to obtain a structure of YqfB based on its two close homologues from the same ASCH family with known good-quality structures: 1t62, a hypothetical protein EF3133 from Enterococcus faecalis V583, and 2z0t, a hypothetical protein PH0355 from Pyrococcus horikoshii OT-3 (Supplementary files 2 and 3). The model was further refined using MD simulations and was found to be of a better quality than that of the published YqfB: all amino acids important for the catalysis were found near the catalytic pocket, accessible for a substrate to bind Supplementary Fig. 11 . Supplementary Fig. 14) . The model was compared with the original experimentally obtained chemical shifts ( 1 H, 13 C, and 15 N) of 1te7 deposited in the BMRB (ID 6207). Notably, NMR experiments were carried out in a buffer solution containing 25 mM Na phosphate, 400 mM NaCl, 1 mM DTT, and 20 mM ZnCl 2 , and such a combination of high ionic strength and reducing conditions likely caused the breakage of the disulphide bond. Hence, the NMR-derived structure may significantly differ from that of a protein in its native state. Nevertheless, we analysed the compatibility of our models with the experimental data using a chemical shift prediction programme SHIFTX2 22 . The analysis showed that both the individual models and the multi-model ensemble obtained during this study are more compatible with the NMR data than those of 1te7 ( Supplementary Table 4 ). Consequently, our models were used for further elucidation of the catalysis mechanism.
Docking studies produced a handful of structures, with ac4C residing within a pocket near catalytically important amino acids. These structures were further simulated using MD (20 ns per structure) to find substrate binding modes, which would give good quantitative and qualitative agreement with the proposed mechanism of acid-base catalysis by Lys21, Glu74 and Thr24. Two different protonation states of Lys21 were used in MD simulations, which resulted in similar substrate binding structures. However, in the case of deprotonated Lys21, the reasonable enzyme-substrate complexes were observed more frequently, in contrast to the simulations carried on protonated Lys21. This may be because deprotonated Lys21 mimics the intermediate stage of the reaction, whereas protonated Lys21 -the very beginning. During MD simulations, a set of structures explaining the catalytic properties of mutants were obtained. First, Lys21, Glu74 and Thr24 neatly aligned with the carbonyl group of ac4C, and the distances between relevant groups/atoms observed in the simulations were below 3.5 Å ( Supplementary Figs. 6B and 8) . Second, the aforementioned structures highlighted the role of His70, Tyr98, and Arg26. The latter functions as an atypical oxyanion hole, which, in the case of hydrolases, is usually formed by the hydrogen bond donors from two or more residues, one of which is typically a Gly. Notably, only the Obc1 protein from Burkholderia thailandensis and O-acetyltransferase PatB1 from Bacillus cereus possess an oxyanion hole formed by arginines 23, 24 . The role of YqfB His70 and Tyr89 is to provide the framework for substrate recognition. Tyr89 forms hydrogen bonds with the ribose moiety and heterocyclic nitrogen of ac4C and N 4 -acetylcytosine, respectively. Thus, unsurprisingly, the Tyr89Phe and Tyr89Ala mutants showed diminished catalytic activity, and the effect was more pronounced in the case of the Tyr89Ala, probably due to the secondary effect on the structure. The role of His70 in the mechanism is rather obscure due to its close proximity to Lys21 and Glu74. The His70Ala mutant had a tenfold lower activity on both substrates, indicating the importance of this residue for catalysis, probably due to the partial bonds with carbonyl oxygen in cytidine and cytosine (Fig. 4b) . The secondary function of YqfB His70 may be to provide the proper environment for Lys21 and Glu74. Based both on experimental studies and on theoretical data, the proposed mechanism of YqfB-mediated catalysis is depicted in Fig. 4c .
Our results highlight the importance of proteins belonging to an obscure ASCH superfamily. Though the ASCH proteins are widespread and diverse, their biological functions remain ambiguous because very little experimental data has been published to date. Recently, the crystal structure of an ASCH domain-containing protein from Zymomonas mobilis (ZmASCH) has been determined revealing a ribonuclease activity. The detailed mechanism of RNA hydrolysis is yet to be elucidated, but it has been confirmed that three residues (Tyr47, Lys53, and Ser128) located in a cleft contribute to nucleic acid-binding and RNA cleavage 25 . However, the biological role of ZmASCH remains unclear, and that makes YqfB the only ASCH superfamily protein with known function and mechanism of catalysis.
conclusions
Previously identified as hypothetical protein, the 103-amino acid protein YqfB from E. coli is, to the best of our knowledge, the smallest monomeric amidohydrolase described to date that has a very high specificity (k cat /K m ~2.2 × 10 6 ) for ac4C. YqfB ability to hydrolyse various N 4 -acylated cytosines and cytidines not only sheds light on the long-standing mystery of how ac4C is catabolized in bacteria, but may also prove useful in the development of novel biocatalysts, and should encourage further analysis of proteins belonging to the widespread ASCH superfamily.
Methods
Reagents. The list of reagents used during this work is provided in Supplementary material.
Bacterial strains and plasmids. E. coli DH5alpha and DH10B, E. coli DH10BΔpyrFEC 18 , and E. coli BL21(DE3) (Novagen, Germany) were used as hosts during this study. E. coli DH10BΔpyrFEC yqfB::Km and E. coli BL21(DE3) yqfB::Km were constructed by replacing the yqfB gene with a kanamycin resistance cassette. The Quick and Easy E. coli Gene Deletion Kit (Gene Bridges) was used, following the technical protocol, Version 2.3 (June 2012). Two primers, yqfB_kn_FW and yqfB_kn_RV, were used to replace the target gene yqfB. The primers yqfB_US_FW and yqfB_DS_RV were used to verify gene replacement by PCR. Plasmid vectors pET21b(+), pETDuet-1 (Novagen, Germany), and pQE70 (Qiagen, Germany) were used for cloning and expression of target genes.
Media and growth conditions. LB: 10 g l −1 tryptone, 5 g l −1 yeast extract, 5 g l −1 NaCl; LB agar: LB supplemented with 15 g l −1 agar; BHI (brain heart infusion) (Oxoid): 37 g l −1 . All media were autoclaved for 30 min at 121 °C (1 atm). Ampicillin (0.1 g l −1 ) and kanamycin (0.015 g l −1 ) were used for selection. M9 medium was prepared as described previously 26 with slight modifications. The M9-agarose, 5 × M9 salts, glucose, and casamino acids stock solutions were prepared separately. Casamino acids solution was filter-sterilized, all other solutions were autoclaved for 30 min at 121 °C (1 atm). M9 agarose: 0.2 g l −1 MgSO 4 , 0.01 g l −1 CaCl 2 , 15 g l −1 Thermo Scientific ™ TopVision Agarose; 5 × M9 salts pH 7.4 stock solution: 35 g l −1 Na 2 HPO 4 , 15 g l −1 KH 2 PO 4 , 2.5 g l −1 NaCl, 5 g l −1 NH 4 Cl; 20 g l −1 glucose; 2 g l −1 casamino acids. M9 medium was supplemented with 0.1 g l −1 ampicillin, 0.015 g l −1 kanamycin, 0.023 g l −1 IPTG, 0.02 g l −1 uracil, cytosine, and N 4 -acetylcytosine, as required. purification of N 4 -acetylcytosine deacetylase from E. coli DH10B. The N 4 -acetylcytosine deacetylase was purified from 1 l of E. coli DH10B culture. The cells were grown at 37 °C in 200 ml standard LB medium, using 1 l flasks. Each flask was inoculated with 1 ml of the overnight culture and E. coli was grown with shaking at 180 rpm. The cells were harvested at the late log phase (20 h after inoculation) by centrifugation for 30 min at 4,000 g (4 °C) and washed once with 0.9% NaCl. The cell pellet was resuspended in 2 volumes of 25 mM Tris-HCl buffer, pH 8.0, and disrupted by 4 min sonication at 22 kHz in 20 s periods with 30 s cooling intervals, using 50% amplitude. To obtain a cell-free extract, the lysate was centrifuged for 30 min at 10,000 g (4 °C) to remove the cell debris and undisrupted cells.
All chromatographic separations were carried out with an Äkta Purifier 100 system (GE Healthcare). At each step in the purification, the enzyme activity was analysed by thin layer chromatography (TLC) using N 4 -acetylcytosine as a substrate. Q-Sepharose chromatography was used as the first step in the purification of the protein. The cell-free extract was loaded onto 20 ml HiPrep Q (GE Healthcare) column equilibrated with 25 mM Tris-HCl, pH 8.0 (buffer A). The column was washed with 100 ml of buffer A, and the retained proteins were subsequently eluted with 12 column volumes of a linear salt gradient (0-0.8 M NaCl) in buffer A, at a flow rate of 2 ml min −1 . The fractions with enzyme activity were pooled and dialyzed against 25 mM Tris-HCl buffer, pH 7.2, before loading onto the second ion exchange 5 ml HiTrap ANX column (GE Healthcare) pre-equilibrated with 25 mM Tris-HCl buffer, pH 7.2. After washing with 5 column volumes of the same buffer, deacetylase was eluted with 20 column volumes of a linear gradient (0-0.8 M NaCl) in 25 mM Tris-HCl, pH 7.2, at a flow rate of 1.2 ml min −1 . The fractions with deacetylase activity were pooled, adjusted to 1.3 M saturation with solid ammonium sulphate, and applied to a 5 ml HiTrap Phenyl FF column (GE Healthcare) equilibrated with 1.3 M (NH 4 ) 2 SO 4 in buffer A. Proteins were initially eluted at a flow rate of 1.2 ml min −1 with 1.3 M (NH 4 ) 2 SO 4 in buffer A and then with 75 ml of a decreasing salt gradient (1.3-0 M (NH 4 ) 2 SO 4 ). Pooled fractions with deacetylase activity were again saturated with (NH 4 ) 2 SO 4 to 1.7 M, and the sample was loaded onto a second hydrophobic interaction column 1 ml Resource ISO (GE Healthcare), equilibrated with buffer A containing 1.7 M (NH 4 ) 2 SO 4 . The column was washed with the equilibration buffer, and moderately bound proteins were eluted with 40 column volumes of a linear salt gradient (from 1.7 to 0.7 M (NH 4 ) 2 SO 4 ) in buffer A. The flow rate was maintained at 0.5 ml min −1 . The active fractions were pooled and dialyzed against buffer A. The dialyzed enzyme solution was applied to a Source 15Q column 0.5 by 30 cm (GE Healthcare) pre-equilibrated with the same buffer. The column was well washed with buffer A, and the bound proteins were eluted with 17 column volumes of a linear gradient (0-0.4 M NaCl) in buffer A, at a flow rate of 0.5 ml min −1 . The fractions with the highest deacetylase activity were pooled, dialyzed at 4 °C overnight against buffer A, and concentrated with carboxymethyl cellulose.
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed following the Laemmli method 27 . For protein identification (mass spectrometry), the concentrated protein solution was run on 14% native PAGE. Protein concentration was determined using the Lowry method 28 with bovine serum albumin as a standard.
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(2020) 10:788 | https://doi.org/10.1038/s41598-020-57664-w www.nature.com/scientificreports www.nature.com/scientificreports/ Cloning, expression, purification, and analysis of recombinant YqfB. The yqfB gene was amplified using E. coli DH10B genomic DNA as a template and the following primers: yqfB_21b_FW, yqfB_21b_RV, yqfB_Duet_FW, yqfB_Duet_RV. A 6xHis-tag was introduced at the C-terminus of YqfB by amplifying the E. coli DH10B yqfB gene with primers yqfB_21b_FW and yqfB_21b_RV. The resulting DNA fragment was cloned into the NdeI and XhoI sites of pET21b(+). The N-terminal 6xHis-tag was fused to YqfB by amplifying the E. coli DH10B yqfB gene with primers yqfB_Duet_FW and yqfB_Duet_RV. The resulting DNA fragment was cloned into the BamHI and HindIII sites of pETDuet-1. The tag-free YqfB was obtained by amplifying the E. coli DH10B yqfB gene with primers yqfB_21b_FW and yqfB_Duet_RV, and the resulting DNA fragment was cloned into the NdeI and HindIII sites of the pET21b(+) vector.
A single colony of E. coli BL21(DE3) yqfB::Km cells transformed with either pETDuet-NHis 6 -ygfB or pET21b-ygfB-CHis 6 was inoculated in 5 ml LB medium containing 100 µg/ml ampicillin and incubated at 37 °C with shaking (180 rpm) overnight. Two millilitres of the overnight culture were transferred to 200 ml of LB medium in a 1 l shake flask. The culture was grown under the same conditions until A 600 reached 0.6. Then IPTG was added to a final concentration of 0.5 mM, and the incubation was continued for additional 4 h. The cells were then harvested by centrifugation for 30 min at 4,000 g (4 °C), resuspended in buffer A and disrupted by sonication (1 min (10 s disruption, 15 s cooling) at 22 kHz and 40% amplitude). The insoluble debris was removed by centrifugation, and the clear supernatant was used for protein purification. The cell-free extract was applied onto a 5 ml Ni 2+ HiTrap chelating HP column (GE Healthcare), equilibrated with buffer A. After a 5-column volume wash with buffer A, the His-tagged protein was eluted with 9 column volumes of a linear imidazole (0-0.5 M) gradient in buffer A, at a flow rate of 1 ml min −1 . To remove the imidazole, a fraction with deacetylase activity was selected, placed into a dialysis bag and dialyzed overnight at 4 °C in buffer A. The purified protein was concentrated with carboxymethyl cellulose and stored at −20 °C.
The tag-free recombinant YqfB protein was expressed from the plasmid vector pET21b-yqfB. Cell cultivation, protein overexpression, and the preparation of a cell-free extract were performed as described above. The cell-free extract was applied onto a 5 ml HiTrap ANX column (GE Healthcare) pre-equilibrated with buffer A. After washing with six column volumes of buffer A, the enzyme was eluted with 12 column volumes of a linear gradient (0-0. Determination of sulfhydryl groups. The method described previously 30 was used to determine sulfhydryl groups. An appropriate volume of protein solution (1 mM) was mixed with the reaction buffer (100 mM Tris-HCl, pH 8.0, 1 mM EDTA) to a final volume of 1 ml. Then, 0.01 ml of DTNB (5,5′-dithio-bis-(2-nitrobenzoic acid)) solution (4 mg of DTNB dissolved in 1 ml of reaction buffer) was added. Reaction mixture was incubated at room temperature for 15 min, and the absorbance at 412 nm was measured. The absorbance is expressed as SH mol/mol protein, using the molecular extinction coefficient of 13,600 M −1 cm −1 for 5-thio-2-nitrobenzoic acid.
YqfB activity assay. The activity of YqfB and its mutants was measured by TLC, HPLC-MS, or spectrophotometrically. For TLC analysis, the reaction mixture consisted of 50 mM potassium phosphate buffer (pH 8.0), 10 mM substrate, and an appropriate amount of protein. After the reaction, 1 µl of the mixture was spotted on silica gel-coated (60 F 254 , Merck) aluminium plate, and chloroform:methanol (9:1 v/v) was used as an eluent. The air-dried plates were visualized with UV light (254 nm). For HPLC-MS analysis, the reaction mixture consisted of 50 mM potassium phosphate buffer (pH 8.0), 2.5 mM substrate, and protein (~1 mg ml −1 ). For the spectrophotometric assay, the reaction was started by adding an appropriate amount of protein to buffer supplemented with substrate (0.1-0.5 mM). Then, a decrease in absorbance at either 310 nm (for ac4C and N 4 -acetyl-2′-deoxycytidine) or 295 nm (N 4 -acetylcytosine) was recorded at 22 °C. Rmodeler software (Ubique Calculus Ltd., Lithuania) was used for the calculation of the kinetic parameters. For all calculations, a scheme consisting of simple Michaelis-Menten kinetics with inhibition by the product was used. The dependence of YqfB activity on pH was investigated in pH range from 3 to 10, using 50 mM citrate phosphate buffer (pH 3.0-7.0), 50 mM potassium phosphate buffer (pH 6.0-8.0), 50 mM Tris-HCl buffer (pH 7.0-9.0), and 50 mM glycine-NaOH buffer (pH 9.0-10.0). The study of the dependence of YqfB activity on temperature was carried out in 50 mM potassium phosphate buffer, pH 8.0. To analyse the effect of inhibitors on the activity of YqfB, phenylmethanesulfonyl fluoride (PMSF) and p-hydroxymercuribenzoate (PHMB) were added to the reaction mixture to a final concentration of 1-2 mM. Also, p-chloromercuribenzoate (PCMB, 0.1-1 mM) and ethylenediaminetetraacetic acid (EDTA, 0.5-5 mM) were added before the assay. One unit of activity corresponded to 1 μmol of substrate converted per 1 min.
